0001104659-24-001490.txt : 20240104 0001104659-24-001490.hdr.sgml : 20240104 20240104200917 ACCESSION NUMBER: 0001104659-24-001490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOLINA ARTURO MD CENTRAL INDEX KEY: 0001398940 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 24514151 MAIL ADDRESS: STREET 1: 10990 WILSHIRE BLVD, SUITE 1200 CITY: LOS ANGELES STATE: CA ZIP: 90024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm241954-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-15 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001398940 MOLINA ARTURO MD C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-11-15 4 S 0 1848 16.24 D 22527 D Common Stock 2024-01-02 4 A 0 26250 0.00 A 48777 D Stock Option (right to buy) 23.42 2024-01-02 4 A 0 97500 0.00 A 2034-01-02 Common Stock 97500 97500 D Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. /s/ Matthew Gosling, Attorney-in-Fact for Arturo Molina, MD 2024-01-04